Scientific Program

Welcome to the seminal edition of the Medical Aesthetic Injectable Summit (MAIS) to take place at the Palacio de Congresos of beautiful Marbella in Spain from October 4-5, 2024.

This two-day international Summit aims at casting a light on the essential and realistic facets of aesthetic medicine and plastic surgery evolution in injectables.

Day one delves deep into the implications of neuromodulators and neurostimulators, while day two is dedicated to the exploration of all dermal fillers and biostimulators.

Program Agenda

Day 1 – Neuromodulators
Time
Room 1
Time
Room 2
09:00 – 10:15
Session 1
Basics Science – Back to the Future
09:00 – 10:15
Session 8
New generation expert & open communication
Chair(s): Fauad Hasan, Mark Nestor
Chair(s):
09:00 – 09:05

Introduction
Fauad Hasan

09:05 – 09:20
Does the MoA/Structure of various BoNTs effect their applications in aesthetics?
Prof. Ornella Rossetto

09:20 – 09:35
Engineered Neurotoxins – will this be a reality one day?
Prof. Bal Ram Singh

09:35 – 09:50
Fundamentals of non-interchangeability of BoNT products – what makes them unique?
Prof. Lance Steward

09:50 – 10:05
Does/duration pharmacodynamics for serotype A’s
Prof. RongSheng Jin

10:05 – 10:15
Q&A
10:15 – 10:45
COFFEE BREAK
10:45 – 12:00
Session 2
Product Analysis
10:45 – 12:00
Session9
Laboratoires Vivacy Symposium
Chair(s): Marina Landau, Won Lee
Chair(s):
10:45 – 11:45
11:45 – 12:00
Q&A
12:00 – 13:15
Session 3
Disruptive Innovations
12:00 – 13:15
Session 10
Sponsored Session
Chair(s): Marina Landau, Humberto Antunes
Chair(s):
12:00 – 12:12
Toxin Enhancer – how will change the current dynamics in aesthetics?
Philippe Picaut
12:12 – 12:24
Liquid Formulations – Basic research to Commercial advantage.
Tommy Kearns
12:24 – 12:36
Antidote – reversing bad effects of neurotoxin injection?
Sameer B Shah
12:36 – 13:06
Startup tank
13:06 – 13:15
Q&A
13:15 – 14:30
LUNCH
14:30 – 15:45
Session 4
Competitive Landscape
14:30 – 17:00
Session 11 & 12
From Battle to Consensus – Part 1
Chair(s): Fauad Hasan
Chair(s):
14:30 – 14:40
Intro to the market – Quantitative Aspect
14:30 – 15:00
Toxins- higher doses? more active toxins? toxin enhancers?
a. Higher doses – Mark Nestor
b. Toxin enhancers
14:40 – 14:50
Intro to the market – Qualitative Aspect
15:00 – 15:30
Why did my BTXA injection fail?
a. Immunogenecity (antibodies)
b. All the rest – Marina Landau
14:50 – 15:30
15:30 – 16:00
Diluted toxin and decanting fillers
a. Yes; b. No
15:30 – 15:45
Q&A
16:00 – 16:30
Do we need to have long duration products, is it better for patients?
a. Pro; b. Con
16:30 – 17:00
Is rapid onset with shorter duration better than delayed onset with longe duration?
a. Pro; b. Con
15:45 – 17:00
Session 5
New technologies or indication
Chair(s): Jeremy Green, Marina Landau
15:45 – 16:45
16:45 – 17:00
Q&A
17:00 – 17:30
COFFEE BREAK
17:30 – 19:00
Session 6
Regulatory discussion from global authorities
Getting your product approved
17:30 – 19:00
Session 13
From Battle to Consensus – Part 2
Chair(s):
Chair(s)
17:30 – 18:45
Notified bodies – European Commission
Consultancy and Law firm
17:30 – 18:00
Injection vs other delivery system?
a. Microneedling; b. Topical
18:00 – 18:30
How to address the adverse events with BTX, is anticolinesteraes a real antidote?
a. Pro; b. Con
18:30 – 19:00
Is liquid toxin a real advantage?
a. Pro – Michael Gold
b. Con
19:00 – 19:30
Session 7
MAIS Awards
Day 2 – Fillers
Time
Room 1
Time
Room 2
09:00 – 10:15
Session 14
Basics Science – Back to the Future
09:00 – 10:15
Session 21
New generation expert & open communication
Chair(s): Glenn Prestwich
Chair(s):
09:00 – 09:15

Science of HA Crosslinking: Translating Safe and Scalable Products to the Clinic
Prof. Glenn Prestwich

09:15 – 09:30
Beyond BDDE: New Developments n Dynamic HA Crosslinking
Prof. Jason Burdick

09:30 – 09:45
Modified HA for Regenerative Aesthetics
Prof. Chiara Schiraldi

09:45 – 10:00
Science of Collagen Injectables: Repair and Replacement
Prof. Michael Yu

10:00 – 10:15
Q&A
10:15 – 10:45
COFFEE BREAK
10:45 – 12:00
Session 15
Product Analysis
10:45 – 12:00
Session22
Sponsored Sessions
Chair(s): Thomas Rappl
Chair(s):
10:45 – 11:45
Round table discussion: Aptos, HTL, Laboratoires Vivacy,
11:45 – 12:00
Q&A
12:00 – 13:15
Session 16
Disruptive Innovations
12:00 – 13:15
Session 23
Sponsored Session
Chair(s): Won Lee
Chair(s):
12:00 – 12:36
Lectures
12:36 – 13:06
Startup tank
13:06 – 13:15
Q&A
13:15 – 14:30
LUNCH
14:30 – 15:45
Session 17
Competitive Landscape
14:30 – 17:00
Session 24 & 25
From Battle to Consensus – Part 3
Chair(s): Humberto Antunes, Benjamin Ascher
Chair(s): Thomas Rappl
14:30 – 14:40
Intro to the market – Quantitative Aspect
14:30 – 15:00
Pre injection aspiration
a. Pro
b. Con
14:40 – 14:50
Intro to the market – Qualitative Aspect
15:00 – 15:30
Injectable tools (needle and cannula) vs needleless equipment
a. Injectable tools
b. needleless equipment
14:50 – 15:30
Round table discussion:
Michel Cheron, CEO, Laboratoires Vivacy
George Sulamanidze, CEO, Aptos
Francois Fournier, CEO, HTL
15:30 – 16:00
Is Ultrasound-guide injection a real progress?
a. Yes; b. No
15:30 – 15:45
Q&A
16:00 – 16:30
Diluting, mixing and decanting fillers?
a. Pro; b. Con
16:30 – 17:00
Vascular compromise what is the best protocol?
15:45 – 17:00
Session 18
New technologies or indication
Chair(s): Prof. Glenn Prestwich, Dr. Ting Song Lim
15:45 – 17:57
Fillers treatment optimized by Artificial Intelligence
Dr. Diala Haykal
15:57 – 16:45
16:45 – 17:00
Q&A
17:00 – 17:30
COFFEE BREAK
17:30 – 19:00
Session 19
Injectable fireside chat
17:30 – 19:00
Session 26
From Battle to Consensus – Part 4
Chair(s): Per Heden, Mark Nestor
Chair(s)
17:30 – 18:45
17:30 – 18:00
Temporal lifting technique
a. Yes; b. No
18:00 – 18:30
Biostimulators – When yes? When no?
18:30 – 19:00
DIR: infection or inflammation?
a. Infection
b. Inflammation
19:00 – 19:30
Session 20
MAIS Awards